Unchained Labs launches new gene therapy tool

By The Science Advisory Board staff writers

October 6, 2020 -- Unchained Labs has launched a new gene therapy quantification application on Stunner, its gene therapy platform.

Stunner's new adeno-associated virus (AAV) application provides researchers with a full readout of how many AAV capsids they have, how many capsids are packed with DNA, and if there is any aggregation. This can be achieved in less than one minute and with only 2 µL of sample.

Stunner pulls together ultraviolet-visible concentration from the sample and measures the total protein and DNA in it. Dynamic light scattering identifies AAV capsids based on their size and checks for aggregation. Stunner then combines all the information measured to provide an accurate titer and empty/full ratio.


Copyright © 2020 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.